​

Turnstone Biologics Ownership | Who Owns Turnstone Biologics?

OverviewFinancialsChart

Turnstone Biologics Ownership Summary

Turnstone Biologics is owned by 36.45% institutional investors, 7.70% insiders, and 55.85% retail investors. Orbimed advisors is the largest institutional shareholder, holding 13.39% of TSBX shares.

TSBX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTurnstone Biologics36.45%7.70%55.85%
SectorHealthcare Stocks 488.30%11.08%-399.38%
IndustryBiotech Stocks 307.10%11.11%-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Orbimed advisors3.10M13.39%$1.11M
Bml capital management1.10M4.77%$396.12K
Takeda pharmaceutical895.82K3.87%$321.60K
Point72 asset management816.92K3.53%$293.27K
72 investment549.98K2.38%$225.49K
Hrt financial lp55.86K0.24%$20.00K
Gts securities45.16K0.20%$16.21K
Millennium management38.86K0.17%$15.93K
Xtx topco37.79K0.16%$13.56K
Acadian asset management16.43K0.07%$4.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Takeda pharmaceutical895.82K1.64%$321.60K
72 investment549.98K0.63%$225.49K
Bml capital management1.10M0.30%$396.12K
Orbimed advisors3.10M0.03%$1.11M
Gts securities45.16K0.00%$16.21K
Xtx topco37.79K0.00%$13.56K
Point72 asset management816.92K0.00%$293.27K
Hrt financial lp55.86K0.00%$20.00K
Nordwand advisors---
Pfm health sciences, lp---

Top Buyers

HolderShares% AssetsChange
Gts securities45.16K0.00%45.16K
Hrt financial lp55.86K0.00%43.78K
Xtx topco37.79K0.00%2.04K
Orbimed advisors3.10M0.03%-
Bml capital management1.10M0.30%-

Top Sellers

HolderShares% AssetsChange
Pfm health sciences, lp---932.35K
Sectoral asset management---517.65K
Fil---192.66K
Deltec asset management---106.06K
Point72 asset management816.92K0.00%-62.01K

New Positions

HolderShares% AssetsChangeValue
Gts securities45.16K0.00%45.16K$16.21K

Sold Out

HolderChange
Virtu financial-14.81K
Nordwand advisors-20.00K
Goldman sachs group-20.52K
Citigroup-61.41K
Deltec asset management-106.06K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202523-8,434,667-18.84%361.81%716.67%8-20.00%
Mar 31, 20254-85.71%4,620,451-58.36%190.86%--100.00%1-83.33%
Dec 31, 20242816.67%11,096,493-3.03%481.95%1385.71%6-40.00%
Sep 30, 202424-45.45%11,443,046-9.91%491.63%7-73.08%10-16.67%
Jun 30, 20244410.00%12,701,707-4.85%551.64%268.33%1250.00%

Recent Insider Transactions

DateNameRoleActivityValue
Jul 25, 2023Versant Ventures V, LLC-Buy$2.37M
Jul 25, 2023Versant Ventures V, LLC-Buy$180.34K
Jul 25, 2023Versant Ventures V, LLC-Buy$78.90K
Jul 25, 2023Versant Ventures V, LLC-Buy$71.27K
Jul 20, 2023ORBIMED ADVISORS LLC Buy$5.00M

Insider Transactions Trends

DateBuySell
2025 Q3--
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q35-

TSBX Ownership FAQ

Who Owns Turnstone Biologics?

Turnstone Biologics shareholders are primarily institutional investors at 36.45%, followed by 7.70% insiders and 55.85% retail investors. The average institutional ownership in Turnstone Biologics's industry, Biotech Stocks , is 307.10%, which Turnstone Biologics falls below.

Who owns the most shares of Turnstone Biologics?

Turnstone Biologics’s largest shareholders are Orbimed advisors (3.1M shares, 13.39%), Bml capital management (1.1M shares, 4.77%), and Takeda pharmaceutical (895.82K shares, 3.87%). Together, they hold 22.03% of Turnstone Biologics’s total shares outstanding.

Does Blackrock own Turnstone Biologics?

BlackRock is not among the top 10 institutional shareholders of Turnstone Biologics.

Who is Turnstone Biologics’s biggest shareholder by percentage of total assets invested?

Takeda pharmaceutical is Turnstone Biologics’s biggest shareholder by percentage of total assets invested, with 1.64% of its assets in 895.82K Turnstone Biologics shares, valued at 321.6K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools